Concentra Reports Strong Q3 2026 Results and Raises Full-Year Guidance
Concentra (CON) delivered robust third-quarter 2026 financial results, characterized by significant growth in both revenue and profitability. Total revenue rose 8.6% year-over-year to $622.1 million, fueled by a 4.9% increase in patient visit volume and higher revenue per visit. Net income saw a substantial jump of 36%, reaching $67.8 million, while Adjusted EBITDA grew nearly 18% to $140.2 million. The company's performance was driven by strong demand across its core segments, including occupational health centers and employer services. Following these results, Concentra raised its full-year 2026 revenue and Adjusted EBITDA guidance. Despite a decrease in free cash flow due to working capital timing and tax payments, the board authorized a new $250 million share repurchase program to enhance capital returns.
Tickers: $CON
Topics: Adjusted EBITDA Net Income Occupational Health Patient Volume Revenue Growth